Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-Registry

EASL Recommendations on Treatment of Hepatitis C 2018

(2018) Jean-Michel Pawlotsky et al.   JOURNAL OF HEPATOLOGY

Treatment of hepatitis C: Results in real life

(2018) Christophe Hézode   LIVER INTERNATIONAL

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures

(2018) Mitsutaka Osawa et al.   JOURNAL OF GASTROENTEROLOGY

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

(2018) Roberta D'Ambrosio et al.   JOURNAL OF HEPATOLOGY

Resistance selection using glecaprevir and pibrentasvir in replicons of major hepatitis C virus genotypes

(2017) T. Ng et al.   JOURNAL OF HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2016

(2017)   JOURNAL OF HEPATOLOGY

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

(2017) Louisa Degenhardt et al.   Lancet Global Health

Global distribution and prevalence of hepatitis C virus genotypes

(2014) Jane P. Messina et al.   HEPATOLOGY

Epidemiology and natural history of HCV infection

(2013) Behzad Hajarizadeh et al.   Nature Reviews Gastroenterology & Hepatology